item management s discussion and analysis of financial condition and results of operations overview the company  through its subsidiaries and majority owned partnership  operates in several areas of the healthcare industry 
it manufactures and distributes healthcare products  provides disposal of certain medical waste  and markets certain over the counter and generic drugs 
see item business for a more detailed description and discussion of each of the company s segments 
results of operations the assets and business of scherer  ltd 
s medical business were sold in october and the assets and business of scherer ltd 
s industrial business were sold in october see item business scherer healthcare  ltd 
for a more detailed description of the two transactions 
net sales 
the following table sets forth the net sales of each segment of the company s business for the last three fiscal years in thousands year ended march  net sales medical device and surgical safety disposables segment marquest    scherer  ltd 
   waste management services segment    consumer healthcare products segment   company totals    fiscal vs 
fiscal net sales the company s net sales decreased by to  for fiscal from  for fiscal  however  fiscal includes six months of net sales  or  for the medical business  which was sold in october additionally  fiscal includes twelve months of net sales of  for the industrial business and fiscal only includes six full months of net sales of  for the industrial business  which was sold in october marquest s net sales decreased approximately to  for fiscal from  in fiscal the decrease in net sales is primarily due to a decrease in sales of marquest s medication delivery devices 
sales of these devices are down approximately  in fiscal compared to fiscal  the majority of the decrease is attributable to one major customer who placed a large sales order in fiscal and who did not place a sales order in fiscal the decrease in sales of the medication delivery devices was partially offset by an increase in sales of marquest s abg products which increased approximately  in fiscal compared to fiscal the increase in the abg sales can be attributable to a long term contract signed with a major customer in late fiscal for these products 
scherer ltd 
s net sales decreased approximately to  in fiscal from  in fiscal  however  fiscal includes six months of net sales  or  for the medical business  which was sold in october additionally  fiscal includes twelve months of net sales of  for the industrial business and fiscal only includes six full months of net sales of  for the industrial business  which was sold in october prior to the sale of the industrial business in october  one of scherer ltd 
s significant distributors had substantially reduced its sales orders with scherer ltd 
net sales in the company s waste management services segment  which operates through bio systems  increased to  in fiscal from  in fiscal in fiscal  bio systems increased its net sales by approximately  by securing new medical waste disposal contracts with hospitals 
bio systems feels that hospitals have been more receptive to out sourcing the disposal of their medical waste  and attributes its success in obtaining new hospital contracts to its reusable containers which are more cost effective 
net sales for scherer labs  which operates in the company s consumer healthcare products segment  increased approximately to  in fiscal from  in fiscal the increase in net sales can be attributed to securing new customers and retail outlets during fiscal fiscal vs 
fiscal net sales the company s net sales decreased by to  for fiscal from  for fiscal  however  fiscal includes twelve months of net sales for the medical business  or  and fiscal includes only six months of net sales for the medical business  or  which was sold in october marquest s net sales increased to  in fiscal from  in fiscal marquest s sales for the first quarter of fiscal were low due to a decline in sales to hospitals which marquest believes was due primarily to the uncertainties relating to proposed healthcare reform 
also  many of marquest s distributors purchased high levels of product during the fourth quarter of fiscal which depressed marquest s sales in the first quarter of fiscal in fiscal  marquest implemented a network of independent manufacturer s representatives which supplements its sales force 
scherer  ltd 
s net sales decreased to  in fiscal from  in fiscal  however  fiscal includes twelve months of net sales for the medical business  or  and fiscal includes only six months of net sales for the medical business  or  scherer  ltd 
s net sales for the industrial business increased to  for fiscal from  in fiscal this increase in net sales was primarily due to the introduction of products fabricated from two new fabric lines in late fiscal net sales for bio systems increased approximately to  in fiscal from  in fiscal the increase in sales was due to the continuing acquisition of new medical waste disposal contracts with hospitals 
net sales for the consumer healthcare products segment increased to  for fiscal from  for fiscal this segment achieved a record level of sales of certain over the counter products during the first quarter of fiscal the sales growth can be attributed to an increase in sales to a primary wholesaler to wal mart 
costs and expenses 
the following table sets forth the percentage relationship which the expense line items in the consolidated statement of operations bear to total revenue percentage of revenue year ended march  net sales costs and expenses cost of good sold selling  general  and administrative research and development nonrecurring charges operating income loss the following table sets forth the company s operating margins by operating segment and on a consolidated basis year ended march  medical device and surgical safety disposables segment marquest scherer  ltd 
waste management services segment consumer healthcare products segment consolidated fiscal vs 
fiscal costs and expenses the company s operating income improved to  in fiscal from  in fiscal the company s cost of goods sold decreased to approximately of net sales in fiscal from of net sales in fiscal selling  general and administrative expenses increased to of net sales in fiscal from approximately of net sales in fiscal marquest s operating income decreased to  in fiscal from  in fiscal this decrease is primarily the result of the decrease in net sales combined with an increase in overtime expense in the first quarter of fiscal due to the rework of certain products 
product rework is caused by supplier quality issues  defects in the molded products  and damage to product during assembly and warehousing 
marquest believes that the supplier quality and damage to product issues have been corrected  however  the molded product defects may recur depending on the condition of the molds 
in an effort to reduce molded product defects  marquest has implemented a preventative maintenance program  increased inspections  and improved operator training 
the decrease in net sales and the increase in overtime expense was partially offset by a decrease in the net operating lease expense of its idle warehouse in nogales  arizona of approximately  due to the sublease of two thirds of the warehouse in december and the sublease of the remaining portion in september additionally  marquest wrote off approximately  in fiscal for certain expenses associated with unsuccessful financing transactions with no corresponding expenses incurred in fiscal scherer ltd 
s operating loss decreased slightly to  in fiscal from  in fiscal  however  fiscal includes  of operating income from the medical business which was sold in october the medical business reported operating income in fiscal primarily as a result of an agreement  effective april   which required cordis to reimburse scherer  ltd 
for monthly losses  in total for the period april through september that scherer  ltd 
was incurring under its surgical tray contract with cordis 
the industrial business of scherer  ltd  which was sold in october  reported an operating loss of  for fiscal compared to an operating loss of  in fiscal the operating loss in fiscal for the industrial business can be attributed to the decrease in net sales due to a substantial reduction in sales orders from one of scherer  ltd 
s significant distributors combined with an inventory write down pursuant to the physical count taken for the health pak transaction in october bio systems increased its operating income to  in fiscal from  in fiscal the improved operating performance can be attributed to the increase in net sales from the acquisition of new hospital contracts combined with a significant decrease in bio systems workers compensation insurance expense 
the decrease in insurance expense is primarily due to the conversion in october of bio systems insurance coverage from a fully insured workers compensation program to a partially insured program  to take advantage of bio systems excellent claims history 
the company s consumer healthcare products segment improved its operating income to  in fiscal from  in fiscal while improving its net sales by  as discussed above  this segment was able to maintain  or improve upon  its prior level of operating costs 
cost of goods sold decreased slightly to of net sales in fiscal from approximately of net sales in fiscal and selling  general and administrative expenses decreased to of net sales in fiscal from in fiscal fiscal vs 
fiscal costs and expenses the company reported operating income of  in fiscal compared to an operating loss of  in fiscal the fiscal operating loss includes a nonrecurring charge of  for the write down of two waste incinerator investments 
marquest reported operating income of  in fiscal compared to an operating loss of  in fiscal this improvement is a result of the increase in sales discussed above combined with an emphasis on cost reduction 
marquest reduced manufacturing costs and administrative expenses by reductions in personnel  improved operational efficiencies and increased vertical integration of the manufacturing processes 
additionally  the increase in the manufacturing volume helped improve overhead absorption 
scherer  ltd 
s operating loss decreased to  in fiscal from  in fiscal in fiscal  scherer  ltd 
experienced substantial losses approximately  under its surgical trays contract with cordis 
effective april   scherer  ltd 
entered into a new agreement with cordis which required cordis  among other things  to reimburse scherer  ltd 
a monthly shortfall amount  per month for the period april to july and  per month for the months of august and september to help offset monthly losses incurred under the contract 
the contract was terminated upon the sale of the medical business to cordis medical in october primarily as a result of the new contract  the medical business reported operating income of  in fiscal compared to an operating loss of  in fiscal the industrial business of scherer  ltd 
increased its operating loss to  in fiscal from  in fiscal in late fiscal  scherer  ltd  which is currently operating under the name protective disposable apparel  moved the manufacture of its lab coats to a new workshop where scherer  ltd 
was able to negotiate better labor rates 
bio systems operating income increased to  in fiscal from  in fiscal the operating improvement was attributable to a decrease in insurance expense and a one time sales tax expense in fiscal pursuant to a three year assessment from a sales tax audit 
prior to fiscal  this segment reported consistent increases in net sales but had struggled to improve its operating margins because of pricing pressures in both the hospital and physician markets 
operating income improved to  in fiscal from  in fiscal at the company s consumer healthcare products segment 
this increase was directly attributed to the increase in sales for this segment discussed above 
other income expense 
in fiscal  the company recorded a loss of approximately  from the sale of the industrial business in october primarily due to the write off of the remaining book value of certain intangible assets 
in fiscal  the company recorded a pretax gain of approximately  from the sale of the medical business in october also in fiscal  marquest recorded a gain of approximately  from the sale of its investment in a medical device company 
in november  the company used  of the net proceeds from the sale of the medical business to repay a portion of outstanding loans from affiliates 
primarily as a result of the debt repayment  the company reduced its interest expense incurred on the affiliate debt from approximately  in fiscal to approximately  in fiscal prior to the assignment of the affiliate debt to a nonaffiliate in march 
marquest s interest expense incurred on affiliate debt in fiscal was  compared to  in fiscal in fiscal  marquest received  in a one time royalty related to one of marquest s product lines 
in fiscal  marquest incurred approximately  in certain expenses associated with the merger between marquest and vital signs  inc see item business recent developments 
income taxes 
the company recorded an income tax provision of  and  in fiscal and  respectively  and had a tax benefit of  in fiscal marquest recorded a tax provision of  in fiscal as a result of its settlement with the irs with respect to tax issues related to previous years 
in fiscal  the company excluding marquest utilized tax loss carryforwards and reduced its valuation allowance accordingly 
in fiscal and in prior years  the company significantly increased its valuation allowance against its deferred tax assets mainly related to the tax loss carryforwards 
the company s ability to generate taxable income from operations is dependent upon various factors  many of which are beyond management s control 
accordingly  there can be no assurance that the company will generate future taxable income 
therefore  the realization of the deferred tax assets will be assessed periodically based upon the company s current and anticipated results of operations 
liquidity and capital resources the company cash flows from operating activities 
the company s excluding marquest cash provided by operating activities from continuing operations decreased to approximately  in fiscal from approximately  in fiscal this slight decrease in cash provided from continuing operations can be attributed to the collection in fiscal of the remaining accounts receivable associated with the medical business of scherer ltd 
which was sold in october pursuant to the terms of the sale agreement  scherer  ltd 
retained all accounts receivable associated with the medical business  of which approximately  was collected at the closing of and subsequent to the transaction 
this was partially offset by improvements  primarily due to timing  in the collection of accounts receivable at bio systems and scherer labs of  and  respectively  in fiscal compared to fiscal additionally  due to the timing of payments  the company s accounts payable and accrued expenses increased approximately  in fiscal compared to fiscal discontinuing the operations of biofor has significantly improved the cash flow of the company 
the net cash used by biofor s operations was approximately  in fiscal compared to approximately  in fiscal cash flows from investing and financing activities 
the company s excluding marquest investing activities provided cash of approximately  in fiscal compared to a use of cash from investing activities of approximately  in fiscal in fiscal  the company terminated its  line of credit arrangement with trust company bank now suntrust bank which was fully collateralized by  in cash investments 
the company determined that the line provided no net financial leverage and converted the collateral previously used to secure the line of credit into operating cash 
the company received approximately  in net proceeds from the sale of assets associated with the medical business of scherer ltd 
in fiscal in fiscal  the company received  in net proceeds from the sale of scherer ltd 
s industrial business 
additionally  bio systems increased its capital expenditures by approximately  in fiscal compared to fiscal primarily due to the purchase of new trucks used to transport medical waste 
cash flows from the company s financing activities used cash of approximately  in fiscal compared to a use of cash of only  in fiscal prior to fiscal  scherer scientific  ltd 
and scherer capital company llc scherer cap  entities controlled by robert p 
scherer  jr 
who is the chairman of the board  chief executive officer  and majority shareholder of the company  made loans the affiliate loans to the company and its subsidiaries the proceeds of which were used primarily for working capital and business acquisitions 
the affiliate loans were payable on demand and generally bore interest at prime rate plus 
in november  the company used  of the net proceeds from the sale of the medical business to repay a portion of the affiliate loans 
in january  the company and scherer cap restructured the remaining balance of  on the affiliate loans into a five year promissory note the original note which bore interest at prime rate plus  adjusted quarterly  and was collateralized by shares of marquest common stock owned by the company 
in connection with the dissolution of scherer cap in march  the original note was amended the amended note and subsequently assigned to the four adult children of robert p 
scherer  jr  who are not affiliated with the company 
in exchange for certain considerations   for the principal balance was forgiven and the interest rate was reduced to prime  adjusted quarterly  in the amended note 
as discussed above  the company terminated its line of credit arrangement during the first quarter of fiscal which had borrowings outstanding of  at march  on march   marquest and vsi announced the execution of a merger agreement providing for vsi to acquire marquest 
in the transaction  which is expected to take place in july  marquest would become a wholly owned subsidiary of vsi and vsi would pay marquest shareholders per share in cash for each outstanding share of marquest common stock 
the company owns  shares of marquest common stock directly and holds warrants to purchase an additional  shares of marquest common stock at an exercise price of per share 
in connection with the merger agreement  the company and vsi entered into an agreement pursuant to which vsi has agreed  provided the merger agreement is consummated  to purchase certain assets and product rights previously sold by marquest to the company and to enter into a covenant not to compete for an aggregate purchase price of  the company expects to receive approximately  before the payment of transaction costs and associated income taxes  in total from the above transactions if they are consummated 
the company plans to use a portion of the proceeds to repay the amended note which had a balance of  as of march  the company will evaluate its long term options with regard to the remaining proceeds  however  on a short term basis it plans to invest the proceeds  principally in us treasuries 
management of the company believes that its current cash on hand of approximately  as of march  and its current cash flow are sufficient to maintain its current operations 
marquest with the exception of executive management  marquest operates independently of the company 
cash flows from operating activities 
marquest s cash used from operating activities increased from  in fiscal to  in fiscal primarily due to a decrease in accounts payable and accrued expenses 
the decrease in accounts payable and accrued expenses is due to the payment in fiscal of consulting fees and other costs related to marquest s financing transactions discussed below  and the payment of income taxes and certain legal settlements 
simultaneous with the execution of the merger agreement with vsi  marquest and vsi entered into a dealer agreement which authorizes vsi to distribute marquest s products for a period of two years 
marquest has given of its hospital specialty dealers notice terminating its agreements with such dealers at the end of the required notice period  generally to days from the date of notice 
these dealers provided marquest with approximately  of revenue in fiscal it is uncertain whether the sales through the dealer agreement with vsi will reach the level of sales achieved by the terminated dealers 
primarily as a result of the termination notices  two of marquest s dealers have filed lawsuits against marquest and vsi see item legal proceedings 
these dealers have informed marquest that they are withholding further payment of amounts owed to marquest pending the settlement of the issues raised in their respective lawsuits 
the two dealers combined outstanding accounts receivable as of may  was approximately   through sales in april and may  before certain rebate adjustments 
marquest intends to vigorously contest the lawsuits and pursue the collection of the outstanding accounts receivable 
cash flow from investing and financing activities 
on june   marquest refinanced  of douglas county industrial revenue bonds the bonds  due on december   with a term loan from colorado national bank the bank  the same bank holding the bonds 
in fiscal  marquest and the bank executed an amendment to the term loan agreement  whereby marquest made a principal payment of  and the term of the loan was shortened from july  to january  and the bank released marquest s inventory and accounts receivable as collateral for the loan 
the loan will continue to amortize over its original term with a balloon payment on january  in fiscal  scherer cap  an entity controlled by robert p 
scherer  jr  made an investment in marquest of approximately  net of related transaction costs 
in march  marquest and scherer cap entered into the loan agreement  from which marquest borrowed  to repay  that marquest borrowed from scherer cap in december for working capital purposes 
the loan agreement contemplated the possibility of additional borrowings of  borrowings under the loan agreement  which expires february   bear interest at prime rate plus  are secured by marquest s inventory  building  and equipment  and are represented by the scherer cap notes that are convertible  at the option of scherer cap  into shares of marquest common stock at a conversion price of per share 
additionally  scherer cap invested  in marquest in march through the purchase of  shares of marquest common stock 
in connection with its dissolution in march  scherer cap assigned the loan agreement and the scherer cap notes  and transferred  shares of the marquest common stock that it owned to mr 
scherer  jr 
the remaining  shares of marquest common stock owned by scherer cap were transferred into a voting trust for the benefit of mr 
scherer  jr 
s adult children 
mr 
scherer  jr 
is entitled to vote the shares held in the voting trust 
in november  marquest obtained a revolving line of credit from norwest business credit  inc norwest which expires february  any amounts borrowed against the line of credit will primarily be secured by marquest s trade accounts receivable and will bear interest at norwest s prime rate plus the rate was as of march  
the maximum amount of the line of credit is of marquest s eligible domestic accounts receivable plus of eligible international accounts receivable or  whichever is less 
as of march   marquest had borrowed  against an available borrowing limit on the line of approximately  as of march   marquest was not in compliance with a covenant requiring a specified debt service coverage rate and a covenant that marquest not incur an after tax loss greater than a specified amount 
norwest has waived the requirement of compliance with these covenants as of march   and marquest has negotiated new covenants with norwest providing for a maximum net loss for the first four months of fiscal through july of  and a minimum net worth of  at the end of july and each subsequent month thereafter 
marquest s management expects that the pending merger with vsi will be consummated by the end of july however  if the merger is delayed or does not occur  marquest s management anticipates taking the following actions during fiscal i continue marketing and selling its products through medical surgical dealers and through the dealer arrangement with vsi in domestic markets where vsi has strategic presence  ii renegotiate its current line of credit with norwest and pursue additional financing opportunities that may be available  iii continue to reduce costs and operating expenses  and iv restrict expenditures for capital assets to maintenance of existing equipment and facilities until marquest generates positive operating cash flow 
the viability of marquest during fiscal will be dependent on the consummation of the merger with vsi  or  if the merger is delayed or does not occur  on the successful implementation of some or all of the above actions 

